Dr. Massimo Raimondo, MD

Dr. Raimondo practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Raimondo's NPI, 1508855487, was assigned on October 13, 2005. Dr. Raimondo graduated from University of Palermo in 1986. Dr. Raimondo holds Florida license ME80001.

Dr. Raimondo's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Raimondo's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raimondo practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Raimondo's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Raimondo is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Raimondo's licenses on file in 3 states: Florida, Minnesota and North Carolina.

Dmand AI lists acid reflux, colonoscopy, hemorrhoids and upper GI endoscopy among the conditions Dr. Raimondo treats.

CMS data shows 403 Medicare services from Dr. Raimondo across 14 procedure codes in 2024, for 368 Medicare patients. Medicare paid $37,920 for them.

CMS counts 368 Medicare patients who saw Dr. Raimondo in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raimondo's median patient age at 69, with 52% women.

In 2024, Dr. Raimondo wrote 43 Medicare Part D claims for 23 patients. 70% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $202 in total drug cost. In 2018, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Raimondo for performance year 2024, reported as part of a group. Dr. Raimondo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 93 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Raimondo, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 159 papers to Dr. Raimondo, published from 2004 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Pancreatic Neoplasms, Endosonography and Pancreatitis. Dr. Raimondo has published most often in Dig Liver Dis. Dr. Raimondo's most frequent co-authors are Michael B. Wallace, MD, Timothy Woodward, MD and Surakit Pungpapong, MD.

Dmand AI links Dr. Raimondo to 2 clinical trials. Conditions studied include Exocrine Pancreatic Insufficiency, Pancreatitis, Chronic and Pancreatic Neoplasms.

CMS Open Payments shows 7 general payments to Dr. Raimondo from 3 drug and device companies from 2016 to 2018. Consulting fees make up the largest share, 55% of the total. Abbvie Inc. paid the most, $2,500.

Dmand AI lists 1 award for Dr. Raimondo.

Dr. Raimondo graduated from University of Palermo in 1986. Dr. Raimondo is a member of ACG, AGA and ASGE.

Dr. Raimondo is in network with 10 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.